Introduction
The dogma for treatment of cancer has changed, with the cytotoxic drugs used in chemotherapy regimes set to lose their dominance and be used alongside targeted therapies that are being developed with the aim of more specifically targeting cancer cells.
Research and analysis highlights
In this comprehensive report covering targeted therapies in oncology, BioSeeker Group has analyzed apoptopic agents, protein kinase inhibitors, anti-angiogenic and vascular targeting agents, immunostimulators, antibodies and vaccines in oncology.
This extensive 550+ pages report compiles and analyzes in parallel the progress concerning drug development and competitive situation in the mentioned key oncology targeted therapy areas. The report will not only provide a framework but also a careful identification and evaluation of drug candidates, technologies and competitors.
The number of targeted therapy drugs has risen sharply, as have the number of targets. The fiercest competition in oncology targeted therapy is pointed out and how several big pharma companies are out hunting for promising technology and drugs to complement their internal pipeline.
Scope of this report
- In-depth competitive landscape assessment of the targeted oncology market place; Including more than 340 drugs and pharmaceutical companies
- Thorough review of six major targeting strategies in oncology: Apoptopic agents, Protein kinase inhibitors, Anti-angiogenic and vascular targeting agents, Immunostimulators, Antibodies and Vaccines
- Progress analysis of major cancer indications for respective targeting strategy, including players, drugs, clinical progress and pitfalls
- Includes more than 120 Tables, 60 Boxes and close to 40 Figures
Key reasons to read this report
- Understand the clinical and strategic challenges to the commercialization of six major targeting strategies in oncology
- Assess opportunities and risks for the continued development of targeting agents in major cancer indications.
- Adopt knowledge from this analysis to drive strategic planning decisions in oncology drug development
Other selected research from the 'Oncology' category:
Analytical Tool - Cancer Therapeutic Antibodies
Cytokine Therapy in Oncology Drug Pipeline Update 2012
Other selected research from the 'Vaccines' category:
Competitive Outlook on Antiangiogenesis and Vascular Targeting in Oncology
Competitive Outlook on Non-Antibody Based Cancer Vaccines
Other selected research from the 'Targeted' category:
Genomic Sequencing Technologies for Medicine: Market Prospects 2011-2021
Complete Target Atlas in Oncology Drug Development: From Tumor to Targeted Therapy